Phase
Startup
Xaga Surgical
Antibiotic resistance is an increasing global problem. Xaga Surgical develops a new breed of medical needles that will save the lives and health of patients in the era of antibiotic resistance. The company´s prostate biopsy needle reduces the
bacterial transmission by 96% and thereby reduces the risk of a severe infection.
Inventor of Xaga Surgical technology and an idea generator. Practicing MD, specialist in Urology and Surgery with 15+ years of experience from healthcare.
Did you know?
Did you know that up to 3% of prostate biopsy procedures lead to sepsis?
The life-threatening infection is caused by the biopsy needle pushing bacteria into the body. Andreas Forsvall, MD, wanted to find a safer solution for his patients and thereby started Xaga Surgical.
New technologies for next-gen antibody therapeutics
Single Molecule Nanowire Biosensors for Diagnostics
Medicines for acute systemic inflammatory diseases
Cancer immunotherapies based in cell reprogramming
Introducing the fungal based industrial revolution
Automated microscopy image acquisition and analysis
Fighting iron deficiency
Implants of magnesium alloys
Developing future targeted immunotherapies in cancer
Digital service for patients
Ultrasound analysis for stroke risk assessment
Medical device that reduces pain during vein operation
Cloud-based solutions for genomics data
A reusable, user-friendly, and sustainable pregnancy test
Digital assistive device for post-surgical rehabilitation
Develops the first effective treatment for hypothyroidism
Builds gene therapy viral vectors
Early detection of pancreatic cancer
Bio-based vegan coating for fruits and vegetables
Equipment that improves the function of cultivated cells
Medtech solution for preventing pressure ulcers
Effective treatments for brain tumors
A new suturing choice for abdominal wall closure
Converting waste flows into valuable raw materials
Innovative systemic anti-inflammatory treatments
Safer medical needles for prostate biopsy
